Managing Ependymomas with Stereotactic Radiotherapy
Author Information
Author(s): Stephanie E Combs, Christoph Thilmann, Jürgen Debus, Daniela Schulz-Ertner
Primary Institution: University of Heidelberg
Hypothesis
To assess the role of Fractionated Stereotactic Radiotherapy (FSRT) in the management of ependymomas.
Conclusion
FSRT is well tolerated and highly effective in managing ependymal tumors.
Supporting Evidence
- The 5- and 10-year overall survival rates were 77% and 64%, respectively.
- Patients treated with FSRT for primary irradiation showed an overall survival of 100% at 3 years.
- FSRT was well tolerated by all patients and could be completed without interruptions due to side effects.
Takeaway
Doctors used a special type of radiation therapy called FSRT to treat kids with a brain tumor called ependymoma, and it worked really well without causing bad side effects.
Methodology
FSRT was performed on 19 patients with histologically confirmed ependymomas, with a median age of 15 years, and various treatment approaches were analyzed.
Limitations
The study is retrospective and lacks a control group.
Participant Demographics
Median age was 15 years, with 5 patients younger than 4 years; male:female ratio was 10:9.
Statistical Information
P-Value
p = 0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website